[HTML][HTML] Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Although clinical trials and real-world studies have affirmed the effectiveness and safety of
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …
Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy
The success of vaccination programs is contingent upon irrefutable scientific safety data
combined with high rates of public acceptance and population coverage. Vaccine hesitancy, …
combined with high rates of public acceptance and population coverage. Vaccine hesitancy, …
[PDF][PDF] FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
Background Two US Food and Drug Administration (FDA)-authorized coronavirus disease
2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)…
2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)…
Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study
…, TM Therneau, JM Steckelberg, A Virk… - Clinical Infectious …, 2010 - academic.oup.com
Background The actual risk of prosthetic joint infection as a result of dental procedures and
the role of antibiotic prophylaxis have not been defined. Methods To examine the association …
the role of antibiotic prophylaxis have not been defined. Methods To examine the association …
Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy
RN Theiler, M Wick, R Mehta, AL Weaver, A Virk… - American journal of …, 2021 - Elsevier
BACKGROUND SARS-CoV-2 infection during pregnancy is associated with significant maternal
morbidity and increased rates of preterm birth. For this reason, COVID-19 vaccination in …
morbidity and increased rates of preterm birth. For this reason, COVID-19 vaccination in …
Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility
…, TJ Kowalski, NL Wengenack, A Virk… - Archives of …, 2006 - jamanetwork.com
Objective To compare the demographics, clinical features, susceptibility patterns, and
treatment for skin and soft tissue infections due toMycobacterium fortuitumandMycobacterium …
treatment for skin and soft tissue infections due toMycobacterium fortuitumandMycobacterium …
[PDF][PDF] Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening
…, BD Pollock, ND Shah, G Farrugia, A Virk… - Clin Infect …, 2021 - gestorweb.camfic.cat
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2021. Published by Oxford
University Press for the Infectious Diseases Society of America. This is an Open Access article …
University Press for the Infectious Diseases Society of America. This is an Open Access article …
Analysis of the effectiveness of the Ad26. COV2. S adenoviral vector vaccine for preventing COVID-19
…, AW Williams, AD Badley, J Halamka, A Virk… - JAMA network …, 2021 - jamanetwork.com
Importance Continuous assessment of the effectiveness and safety of the US Food and Drug
Administration–authorized SARS-CoV-2 vaccines is critical to amplify transparency, build …
Administration–authorized SARS-CoV-2 vaccines is critical to amplify transparency, build …
Randomized trial evaluating clinical impact of RAPid IDentification and susceptibility testing for gram-negative bacteremia: RAPIDS-GN
R Banerjee, L Komarow, A Virk… - Clinical Infectious …, 2021 - academic.oup.com
Background Rapid blood culture diagnostics are of unclear benefit for patients with gram-negative
bacilli (GNB) bloodstream infections (BSIs). We conducted a multicenter, randomized, …
bacilli (GNB) bloodstream infections (BSIs). We conducted a multicenter, randomized, …
Myocarditis following coronavirus disease 2019 mRNA vaccine: a case series and incidence rate determination
Y Perez, ER Levy, AY Joshi, A Virk… - Clinical Infectious …, 2022 - academic.oup.com
Background Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines (Pfizer-BioNTech
and Moderna) has been increasingly reported. Incidence rates in the …
and Moderna) has been increasingly reported. Incidence rates in the …
